The average one-year price target for AVITA Medical (NasdaqCM:RCEL) has been revised to 26.69 / share. This is an increase of 6.80% from the prior estimate of 24.99 dated January 16, 2024.
The price target is an average of many targets provided by analysts. The latest targets range from a low of 21.21 to a high of 42.00 / share. The average price target represents an increase of 56.08% from the latest reported closing price of 17.10 / share.